This paper is in the following e-collection/theme issue:

Health Care Quality and Health Services Research (271) Peer-to-Peer Support and Online Communities (636) Caregiving and Parenting for Chronic Pediatric Diseases (82)

Published on in Vol 6, No 4 (2020): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17928, first published .
Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study

Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study

Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey Study

Authors of this article:

Atul T Patel1 Author Orcid Image ;   Theodore Wein2 Author Orcid Image ;   Laxman B Bahroo3 Author Orcid Image ;   Ophélie Wilczynski4 Author Orcid Image ;   Carl D Rios5 Author Orcid Image ;   Manuel Murie-Fernández6 Author Orcid Image
Article Authors Cited by (13) Tweetations (3) Metrics

Journals

  1. Gracies J, Francisco G, Jech R, Khatkova S, Rios C, Maisonobe P. Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis. Journal of Neurologic Physical Therapy 2021;45(3):203 View
  2. Newsome S, Thrower B, Hendin B, Danese S, Patterson J, Chinnapongse R. Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported survey. Multiple Sclerosis and Related Disorders 2022;68:104376 View
  3. Jacinto J, Lysandropoulos A, Leclerc M, Calvi-Gries F. Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study. Frontiers in Neurology 2022;13 View
  4. Courtet P, Pecout C, Lainé-Pellet A, Chekroun M, Avril C, Mourad J. Patients’ Perspectives About the Treatment They Receive for Cardiovascular Diseases and Mental Disorders: Web-Based Survey Study. JMIR Formative Research 2022;6(3):e32725 View
  5. Ahmedy F, Mohd Tuah N, Mohamad Hashim N, Sybil Shah S, Ahmedy I, Tan S. Revisiting Spasticity After Stroke: Clustering Clinical Characteristics for Identifying At-Risk Individuals. Journal of Multidisciplinary Healthcare 2021;Volume 14:2391 View
  6. Levy J, Karam P, Forestier A, Loze J, Bensmail D. Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France. Frontiers in Neurology 2023;14 View
  7. Bezzina C, Degtiar V, Danchenko N, Maisonobe P, Davis B, Engmann E, Guyon E, Lecanuet S, Whalen J. A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity. Toxins 2023;15(9):532 View
  8. Nomikos N, Eleftheriou C, Athanasakis K. A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece. Toxins 2023;15(9):561 View
  9. Hassan A, Salihu A, Masta M, Gunn H, Marsden J, Abdullahi A, Ahmad R, Danazumi M. Effect of transcutaneous spinal direct current stimulation on spasticity in upper motor neuron conditions: a systematic review and meta-analysis. Spinal Cord 2023;61(11):587 View
  10. Thrower B, Newsome S, Hendin B, Danese S, Patterson J, Chinnapongse R. Recognition, Description, and Variability of Spasticity in Individuals With Multiple Sclerosis and Potential Barriers to Clinician-Patient Dialogue: Results From SEEN-MSS, a Large-Scale, Self-Reported Survey. International Journal of MS Care 2024;26(2):75 View
  11. Zerbinati P, Mazzoli D, Galletti M, Basini G, Rambelli C, Mascioli F, Bò M, Delia C, Petroselli L, Vulpiani M, Prati P, Bemporad J, Merlo A. A survey on the short to medium-term satisfaction of neurological patients treated by functional surgery for the correction of limb deformities. Current Medical Research and Opinion 2024;40(6):957 View
  12. Patel A, Munin M, Ayyoub Z, Francisco G, Kazerooni R, Gross T. A randomized, double‐blind, placebo‐controlled trial of DaxibotulinumtoxinA for Injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury. PM&R 2024 View